Taiwan Society of Colon and Rectal Surgeons Consensus on mCRC Treatment

Therapeutic options for metastatic CRC (mCRC) have changed significantly in recent years, greatly increasing the complexity of therapeutic decision-making. Although oncology guidelines have helped improve the care process, guidelines may also limit the flexibility to individualize in-clinic decision...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Hong-Hwa Chen, Tao-Wei Ke, Ching-Wen Huang, Jeng-Kae Jiang, Chou-Chen Chen, Yao-Yu Hsieh, Hao-Wei Teng, Bo-Wen Lin, Yi-Hsin Liang, Yu-Li Su, Hung-Chih Hsu, Feng-Che Kuan, Yenn-Hwei Chou, Johnson Lin, Ben-Ren Lin, Yu-Yao Chang, Jaw-Yuan Wang
Format:	article
Langue:	EN
Publié:	Frontiers Media S.A. 2021
Sujets:	Taiwan metastatic colorectal cancer treatment consensus molecular biomarker disease management in real world practice Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/51101c1ebda440049aea4e70c061c41a
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!

Taiwan Society of Colon and Rectal Surgeons Consensus on mCRC Treatment

Documents similaires